A mission-driven venture capital backed seed stage company
Jeeva is on a mission to reduce the travel burden on patients in clinical research by replacing up to 80 percent of in-person site visits with remote monitoring and digital engagement. Our Jeeva Clinical SaaS Platform supports clinical research studies involving long-term follow-ups and safety monitoring.
After suffering the loss of a child to a rare congenital disorder, Jeeva founder and CEO Harsha Rajasimha applied his years of postdoctoral training in the United States at the National Institutes of Health and the U.S. Food and Drug Administration, as well as his work in the life science industry, to accelerating treatments for rare diseases by eliminating bottlenecks in the clinical trials process.
Jeeva identified travel requirements for clinical trial patients as a major barrier to recruitment and retention. The COVID-19 pandemic is accelerating the demand to decentralize the way clinical trials are conducted. Sponsors, investigators, regulators, and participants are all embracing the potential of digital technologies to reduce the cost, increase the speed, and ease the burden on participants in these studies.